In the tumor microenvironment, PD-1, a cell surface receptor expressed on a variety of immune cells, and its ligand PD-L1, expressed in tumor cells and antigen-presenting cells (APCs), play a critical role in tumor progression and survival by escaping immune surveillance [60]. This evidence concerns the gene PDCD1 and neoplasm.